Literature DB >> 16108854

Can a screening programme for diabetes be applied to another population?

C Glümer1, K Borch-Johnsen, S Colagiuri.   

Abstract

AIMS: To compare the performance of a Danish diabetes screening protocol in populations from Denmark and Australia.
METHODS: The populations used were the Inter99 population from Denmark and the AusDiab population from Australia. The Inter99 study included 6270 individuals aged 30-60 years, randomly selected from Copenhagen County. The AusDiab study included 7079 individuals also aged 30-60 years, randomly selected from throughout Australia. In both studies, all individuals without known diabetes underwent an oral glucose tolerance test (OGTT). Screening using a Danish risk score as an initial step was followed by measurement of fasting plasma glucose (FPG).
RESULTS: The characteristics of the study populations showed some differences in risk profile, with more individuals in the AusDiab study being obese, whilst in the Danish cohort, mean blood pressure was higher, less people took anti-hypertensive medication and there was a higher prevalence of screen-detected diabetes. Comparing the Australian and Danish populations, overall performance of the screening protocol was similar-area under area receiver operator characteristic (ROC) curve 0.75 vs. 0.77, sensitivity 71 vs. 76% and positive predictive value (PPV) 6 vs. 9%. Small but statistically significant differences were observed in specificity (70 vs. 66%; P < 0.001) and percentage of the population requiring further testing (31 vs. 36%; P < 0.001). Combining the risk score with FPG > or = 6.1 mmol/l showed a similar pattern. Again, specificity was slightly but significantly higher in the Australian population (95 vs. 93%; P < 0.001) and percentage of the population requiring further testing was lower (5 vs. 8%; P < 0.001).
CONCLUSIONS: The Danish risk score performed well when applied to a geographically different Caucasian population and is a suitable tool for detecting people at high risk of undiagnosed diabetes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16108854     DOI: 10.1111/j.1464-5491.2005.01641.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  8 in total

1.  Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening.

Authors:  Ben Schöttker; Elke Raum; Dietrich Rothenbacher; Heiko Müller; Hermann Brenner
Journal:  Eur J Epidemiol       Date:  2011-09-27       Impact factor: 8.082

Review 2.  Nonpharmacological interventions for the prevention of type 2 diabetes mellitus.

Authors:  Peter E Schwarz; Colin J Greaves; Jaana Lindström; Thomas Yates; Melanie J Davies
Journal:  Nat Rev Endocrinol       Date:  2012-01-17       Impact factor: 43.330

Review 3.  Who should we target for diabetes prevention and diabetes risk reduction?

Authors:  Susann Blüher; Jana Markert; Sabine Herget; Thomas Yates; Melanie Davis; Gabriele Müller; Thomas Waldow; Peter E H Schwarz
Journal:  Curr Diab Rep       Date:  2012-04       Impact factor: 4.810

Review 4.  Early diagnosis and prevention of diabetes in developing countries.

Authors:  Ramachandran Ambady; Snehalatha Chamukuttan
Journal:  Rev Endocr Metab Disord       Date:  2008-07-07       Impact factor: 9.306

5.  Reporting and handling of missing data in predictive research for prevalent undiagnosed type 2 diabetes mellitus: a systematic review.

Authors:  Katya L Masconi; Tandi E Matsha; Justin B Echouffo-Tcheugui; Rajiv T Erasmus; Andre P Kengne
Journal:  EPMA J       Date:  2015-03-11       Impact factor: 6.543

6.  A simple risk score for identifying individuals with impaired fasting glucose in the Southern Chinese population.

Authors:  Hui Wang; Tao Liu; Quan Qiu; Peng Ding; Yan-Hui He; Wei-Qing Chen
Journal:  Int J Environ Res Public Health       Date:  2015-01-23       Impact factor: 3.390

7.  Reanalysis and External Validation of a Decision Tree Model for Detecting Unrecognized Diabetes in Rural Chinese Individuals.

Authors:  Zhong Xin; Lin Hua; Xu-Hong Wang; Dong Zhao; Cai-Guo Yu; Ya-Hong Ma; Lei Zhao; Xi Cao; Jin-Kui Yang
Journal:  Int J Endocrinol       Date:  2017-05-30       Impact factor: 3.257

8.  Validating prediction scales of type 2 diabetes mellitus in Spain: the SPREDIA-2 population-based prospective cohort study protocol.

Authors:  Miguel Ángel Salinero-Fort; Carmen de Burgos-Lunar; José Mostaza Prieto; Carlos Lahoz Rallo; Juan Carlos Abánades-Herranz; Paloma Gómez-Campelo; Fernando Laguna Cuesta; Eva Estirado De Cabo; Francisca García Iglesias; Teresa González Alegre; Belén Fernández Puntero; Luis Montesano Sánchez; David Vicent López; Víctor Cornejo Del Río; Pedro J Fernández García; Concesa Sabín Rodríguez; Silvia López López; Pedro Patrón Barandío
Journal:  BMJ Open       Date:  2015-07-28       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.